Key Safety Considerations Despite its biological activity, IGF-1 LR3 raises several concerns: Blood glucose disruption: hypoglycemia is a known risk Fluid retention and musculoskeletal discomfort: commonly reported Metabolic effects: potential insulin resistance with extended exposure Oncogenic signaling: persistently elevated IGF-1 levels have been linked to certain cancers Regulatory Reality Not FDA-approved for therapeutic or lifestyle use Banned in competitive sports by anti-doping agencies Limited clinical evidence: lacks robust, long-term human safety trials A Cautious Outlook While IGF-1 LR3 provides valuable insights into growth factor biology, its translation beyond controlled research environments remains unresolved
Other common species are the reptiles: the emerald boa (Corallus caninus), the machaco parrot (Bothriopsis bilineata), the boa constrictor (Boa constrictor) and the shushupe (Lachesis muta)
If a blood test measuring these substances is performed shortly after eating or drinking, the results will reflect the temporary influence of the meal, rather than your typical, baseline levels
The Peptide Therapy Boom Has a Software Problem Peptide therapy is no longer a niche corner of functional medicine
Baby skin is more delicate, so always use a product specifically formulated for babies, like CITTA Moisturizing Baby Balm
